1y return+39.5%S&P 500 +20.9%
3y return+32.0%S&P 500 +68.5%
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
$100 invested in its stock picks
Since December 31, 2022: $132 against $195 in the S&P 500.2
Boone Capital Management LLCS&P 500 (SPY)
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| TFXTeleflex Incorporated | $49.1M | 11.5% | +39.0% |
| MIRMMirum Pharmaceuticals Inc | $48.7M | 11.4% | −1.3% |
| CIThe Cigna Group | $43.9M | 10.3% | +15.8% |
| IONSIonis Pharmaceuticals Inc | $41.2M | 9.6% | +3.9% |
| UNHUnitedhealth Group Inc | $36.9M | 8.6% | +11.9% |
| BMRNBiomarin Pharmaceutical Inc | $33.4M | 7.8% | +6.5% |
| GRDNGuardian Pharmacy Svcs Inc | $29.8M | 7.0% | +12.8% |
| VSTSVestis Corporation | $27.6M | 6.5% | New |
| BBIOBridgebio Pharma Inc | $25.3M | 5.9% | +48.5% |
| PNTGPennant Group Inc | $19.1M | 4.5% | New |
| GLUEMonte Rosa Therapeutics Inc | $14.9M | 3.5% | New |
| KODKodiak Sciences Inc | $14.7M | 3.4% | +34.4% |
| TNGXTango Therapeutics Inc | $14.2M | 3.3% | New |
| KYMRKymera Therapeutics Inc | $13.0M | 3.0% | New |
| CGEMCullinan Therapeutics Inc | $12.8M | 3.0% | New |
| ANLAdlai Nortye Ltd | $3.0M | 0.7% | New |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| MIRMMirum Pharmaceuticals Inc | September 30, 2023 | +270.5% | $48.7M |
| KODKodiak Sciences Inc | September 30, 2025 | +138.0% | $14.7M |
| BBIOBridgebio Pharma Inc | September 30, 2025 | +43.4% | $25.3M |
| UNHUnitedhealth Group Inc | June 30, 2025 | +33.2% | $36.9M |
| IONSIonis Pharmaceuticals Inc | September 30, 2025 | +21.2% | $41.2M |
| GRDNGuardian Pharmacy Svcs Inc | March 31, 2026 | +11.2% | $29.8M |
| TFXTeleflex Incorporated | March 31, 2026 | +6.0% | $49.1M |
| CIThe Cigna Group | December 31, 2022 | −16.8% | $43.9M |
| BMRNBiomarin Pharmaceutical Inc | March 31, 2025 | −19.1% | $33.4M |
Sold off last quarter
- Medtronic PLCCUSIP G5960L103 was $34.5M
- Astrazeneca PLCCUSIP G0593M107 was $21.7M
- Avanos Med IncCUSIP 05350V106 was $16.6M
- TENXTenax Therapeutics Inc was $3.2M
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +11.9% | +14.8% |
| March 31, 2026 | −0.3% | −4.6% |
| December 31, 2025 | +16.4% | +2.4% |
| September 30, 2025 | +7.5% | +7.8% |
| June 30, 2025 | −4.6% | +10.5% |
| March 31, 2025 | −0.9% | −4.6% |
| December 31, 2024 | −5.4% | +2.1% |
| September 30, 2024 | +11.7% | +5.4% |
| June 30, 2024 | −11.9% | +4.0% |
| March 31, 2024 | +4.0% | +10.0% |
| December 31, 2023 | +4.5% | +11.2% |
| September 30, 2023 | −1.2% | −3.6% |
| June 30, 2023 | +9.5% | +8.3% |
| March 31, 2023 | −9.0% | +7.0% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Boone Capital Management LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1882053&type=13F-HR&dateb=&owner=include&count=40CIK 1882053
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1882053/000121465926010362/Filed August 14, 2026 · accession 0001214659-26-010362